Your browser is no longer supported. Please, upgrade your browser.
Agile Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.70 Insider Own0.80% Shs Outstand87.63M Perf Week-8.44%
Market Cap125.25M Forward P/E- EPS next Y-0.27 Insider Trans18.81% Shs Float67.94M Perf Month-14.55%
Income-61.10M PEG- EPS next Q-0.21 Inst Own48.70% Short Float9.23% Perf Quarter-31.88%
Sales0.90M P/S139.17 EPS this Y-62.70% Inst Trans-4.80% Short Ratio5.59 Perf Half Y-51.38%
Book/sh0.40 P/B3.52 EPS next Y62.00% ROA-75.20% Target Price- Perf Year-49.10%
Cash/sh0.45 P/C3.12 EPS next 5Y- ROE-105.70% 52W Range1.28 - 3.89 Perf YTD-50.87%
Dividend- P/FCF- EPS past 5Y15.00% ROI-74.70% 52W High-63.75% Beta0.97
Dividend %- Quick Ratio4.80 Sales past 5Y- Gross Margin-66.80% 52W Low10.16% ATR0.08
Employees28 Current Ratio5.00 Sales Q/Q- Oper. Margin- RSI (14)33.43 Volatility4.38% 4.27%
OptionableYes Debt/Eq0.44 EPS Q/Q-90.10% Profit Margin- Rel Volume0.73 Prev Close1.45
ShortableYes LT Debt/Eq0.44 EarningsMay 04 AMC Payout- Avg Volume1.12M Price1.41
Recom1.60 SMA20-10.65% SMA50-15.32% SMA200-45.00% Volume818,300 Change-2.76%
Apr-07-21Resumed RBC Capital Mkts Outperform $8
Apr-12-19Resumed Janney Buy $4
Nov-29-18Initiated Maxim Group Buy $3
Dec-26-17Downgrade William Blair Outperform → Mkt Perform
Dec-26-17Downgrade Janney Buy → Neutral
Oct-02-17Resumed H.C. Wainwright Buy $10
Sep-14-17Reiterated RBC Capital Mkts Outperform $8 → $10
Jul-19-17Initiated H.C. Wainwright Buy $10
Jan-08-16Initiated Cantor Fitzgerald Buy
Apr-02-15Initiated FBR Capital Outperform $17
Jun-17-14Initiated William Blair Outperform
Jun-17-14Initiated RBC Capital Mkts Outperform $12
May-26-21 08:05AM  
May-12-21 08:00AM  
May-05-21 08:01AM  
May-04-21 07:15PM  
Apr-30-21 11:01AM  
Apr-20-21 10:56AM  
Apr-09-21 02:16PM  
Mar-05-21 07:30AM  
Mar-01-21 11:31PM  
Feb-19-21 08:35AM  
Jan-04-21 12:18PM  
Jan-03-21 11:12PM  
Dec-21-20 07:30AM  
Dec-12-20 01:23PM  
Dec-07-20 07:30AM  
Nov-30-20 09:11AM  
Nov-23-20 10:00AM  
Nov-13-20 06:02AM  
Nov-12-20 04:05PM  
Nov-04-20 07:30AM  
Sep-22-20 11:40AM  
Sep-09-20 08:00AM  
Sep-08-20 08:00AM  
Sep-02-20 09:00AM  
Aug-17-20 08:00AM  
Aug-11-20 04:02PM  
Jul-21-20 07:30AM  
Jul-01-20 01:22AM  
Jun-23-20 08:30AM  
Jun-16-20 08:00AM  
Jun-10-20 09:35AM  
May-28-20 12:37PM  
May-11-20 04:05PM  
May-07-20 08:36AM  
May-05-20 04:01PM  
May-04-20 12:07PM  
Apr-23-20 07:30AM  
Apr-22-20 08:00AM  
Apr-01-20 05:50PM  
Mar-23-20 04:31PM  
Mar-18-20 08:49AM  
Mar-15-20 04:02PM  
Mar-03-20 03:00PM  
Feb-25-20 11:41AM  
Feb-21-20 12:00PM  
Feb-20-20 04:14PM  
Feb-14-20 06:46PM  
Feb-12-20 09:18AM  
Feb-11-20 08:46AM  
Feb-10-20 04:30PM  
Feb-03-20 01:30PM  
Jan-28-20 01:48PM  
Jan-10-20 09:33AM  
Jan-09-20 06:19AM  
Jan-07-20 10:22AM  
Jan-06-20 08:14AM  
Jan-03-20 07:55AM  
Jan-02-20 08:00AM  
Dec-23-19 08:36AM  
Dec-19-19 04:05PM  
Dec-14-19 06:59PM  
Nov-15-19 10:09AM  
Nov-14-19 04:30PM  
Nov-11-19 04:40PM  
Nov-05-19 06:53AM  
Nov-04-19 11:24AM  
Oct-31-19 01:11PM  
Oct-30-19 06:33PM  
Oct-29-19 05:24PM  
Oct-28-19 08:00AM  
Oct-25-19 09:30AM  
Oct-14-19 12:17AM  
Oct-01-19 09:44AM  
Sep-30-19 11:16PM  
Sep-25-19 08:23AM  
Sep-19-19 10:29AM  
Sep-10-19 09:00AM  
Sep-06-19 07:30AM  
Sep-05-19 10:12AM  
Aug-30-19 09:45AM  
Aug-22-19 10:50AM  
Aug-08-19 04:15PM  
Aug-02-19 09:05AM  
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALTOMARI ALFREDChief Executive OfficerMay 18Buy1.6120,00032,200488,710May 19 08:30 AM
Reilly DennisChief Financial OfficerMay 11Buy1.3520,00027,000176,306May 12 04:31 PM
Butch JasonPrincipal Accounting OfficerMar 29Buy1.991,3582,70220,000Mar 30 04:48 PM
Butch JasonPrincipal Accounting OfficerMar 26Buy2.018,64217,37018,642Mar 30 04:48 PM
Reilly DennisChief Financial OfficerMar 23Buy2.0550,000102,500156,306Mar 23 05:23 PM
ALTOMARI ALFREDChief Executive OfficerMar 23Buy2.0012,50025,030468,710Mar 23 05:24 PM
Conway Robert GSVP Chief Supply Chain OfficerNov 19Option Exercise1.764,1497,30222,896Nov 23 05:00 PM
Reilly DennisChief Financial OfficerSep 28Buy2.859,00025,650106,306Sep 28 04:10 PM
ALTOMARI ALFREDChief Executive OfficerAug 20Option Exercise1.7694,599166,494456,210Aug 20 04:15 PM
ALTOMARI ALFREDChief Executive OfficerJun 22Option Exercise1.7650,00088,000361,611Jun 23 05:00 PM